Gupta R S, Singh B, Stetsko D K
Carcinogenesis. 1985 Sep;6(9):1359-66. doi: 10.1093/carcin/6.9.1359.
In Chinese hamster V79 cells, stable mutants which are greater than 1000-fold resistant to the adenosine analog, tubercidin (Tubr mutants), and which exhibit high degree of cross-resistance to various other adenosine analogs, viz. toyocamycin, formycin A, 6-methylmercaptopurine riboside and 8-azaadenosine, have been isolated. The inability of the mutant cells to phosphorylate [3H]tubercidin and lack of adenosine kinase activity (AK- phenotype) in their cell extracts provide evidence that the mutant cells are unable to convert adenosine analogs into their toxic phosphorylated derivatives. When AK- cells are co-cultured with increasing numbers of parental V79 (AK+) cells in medium containing tubercidin, then due to metabolic cooperation between AK+ and AK- cells, a cell density-dependent decline in recovery of the resistant cells is observed. However, diphtheria toxin resistant (Dipr) mutants of V79 cells, which are altered in elongation factor-2, showed no similar cell density effect. Addition of 0.01 microgram/ml of phorbol ester, 12-O-tetradecanoyl-phorbol-13-acetate (TPA) to growth medium in these experiments markedly enhanced the recovery of the Tubr mutants, but it had no effect on the recovery of Dipr mutants, which suggests that TPA was enhancing recovery of AK- mutants by inhibiting metabolic cooperation between AK- and AK+ cells. Maximum effect of TPA on the recovery of AK- mutants (3- to 5-fold enhancement) was observed at a density of 6 X 10(5) V79 cells/60 mm diameter dish and it was independent of the particular adenosine analog that was used as selective agent. Studies with a number of different phorbol derivatives show that only those phorbol esters which show tumor promoting activity in the mouse skin system inhibited metabolic cooperation between AK+/AK- cells in a dose-dependent manner. An excellent correlation was observed in these studies between the relative tumor promoting activity of various phorbol esters, their relative binding affinities to the cell surface receptors, and the concentrations at which they inhibited metabolic cooperation in the AK-/AK+ cell system. The AK-/AK+ cell system thus provides a new system for examining the effect of tumor promoters on metabolic cooperation between cells.
在中国仓鼠V79细胞中,已分离出对腺苷类似物结核菌素具有大于1000倍抗性的稳定突变体(Tubr突变体),这些突变体对各种其他腺苷类似物,即丰加霉素、间型霉素A、6-甲基巯基嘌呤核苷和8-氮杂腺苷,表现出高度的交叉抗性。突变细胞无法将[3H]结核菌素磷酸化,且其细胞提取物中缺乏腺苷激酶活性(AK-表型),这表明突变细胞无法将腺苷类似物转化为其有毒的磷酸化衍生物。当AK-细胞与越来越多的亲代V79(AK+)细胞在含有结核菌素的培养基中共培养时,由于AK+和AK-细胞之间的代谢合作,观察到抗性细胞的回收率呈细胞密度依赖性下降。然而,V79细胞中在延伸因子-2方面发生改变的抗白喉毒素(Dipr)突变体没有表现出类似的细胞密度效应。在这些实验中,向生长培养基中添加0.01微克/毫升的佛波酯12-O-十四酰佛波醇-13-乙酸酯(TPA)显著提高了Tubr突变体的回收率,但对Dipr突变体的回收率没有影响,这表明TPA通过抑制AK-和AK+细胞之间的代谢合作来提高AK-突变体的回收率。在6×10⁵个V79细胞/60毫米直径培养皿的密度下观察到TPA对AK-突变体回收率的最大效应(提高3至5倍),且该效应与用作选择剂的特定腺苷类似物无关。对多种不同佛波酯衍生物的研究表明,只有那些在小鼠皮肤系统中表现出促肿瘤活性的佛波酯以剂量依赖性方式抑制AK+/AK-细胞之间的代谢合作。在这些研究中,观察到各种佛波酯的相对促肿瘤活性、它们与细胞表面受体的相对结合亲和力以及它们在AK-/AK+细胞系统中抑制代谢合作的浓度之间存在极好的相关性。因此,AK-/AK+细胞系统为研究肿瘤启动子对细胞间代谢合作的影响提供了一个新系统。